Roche's Elecsys Amyloid Plasma Panel granted FDA Breakthrough Device Designation to enable a timely diagnosis of Alzheimer’s disease July 19, 2022July 30, 2022 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: Roche provides update on Alzheimer’s Prevention…Roche launches new BenchMark ULTRA PLUS system for…Thermo Fisher Scientific Updates TaqMan SARS-CoV-2…Roche to present scientific progress across…[Ad hoc announcement pursuant to Art. 53 LR] Roche…Roche COVID-19 At-Home Test granted FDA Emergency…
